SEC Form 4 · accession 0000914190-26-000114
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven C. Crouse
Officer — President - Diag & Spatial Bi
Period of report
Aug 15, 2026
Accepted (ET)
Aug 18, 2026 · 4:13 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 15, 2026 | M | 5,423 | $0.00 | A | 12,184 | D | |
| Common Stock | Aug 15, 2026 | F | 1,947 | $72.40 | D | 10,237 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F4 | — | Aug 15, 2026 | M | 1,379 | D | — | — | Common Stock | 1,379 | 0 | D |
| Restricted Stock UnitsF1,F5 | — | Aug 15, 2026 | M | 1,868 | D | — | — | Common Stock | 1,868 | 1,869 | D |
| Restricted Stock UnitsF1,F6 | — | Aug 15, 2026 | M | 2,176 | D | — | — | Common Stock | 2,176 | 4,353 | D |
| Restricted Stock UnitsF1,F2 | — | holding | — | — | — | — | — | Common Stock | 794 | 794 | D |
| Restricted Stock UnitsF1,F3 | — | holding | — | — | — | — | — | Common Stock | 1,200 | 1,200 | D |
| Stock Option (right to buy)F7 | $97.13 | holding | — | — | — | — | Apr 1, 2028 | Common Stock | 3,856 | 3,856 | D |
| Stock Option (right to buy)F7 | $120.46 | holding | — | — | — | — | Aug 6, 2028 | Common Stock | 19,032 | 19,032 | D |
| Stock Option (right to buy)F8 | $94.52 | holding | — | — | — | — | Aug 15, 2029 | Common Stock | 24,560 | 24,560 | D |
| Stock Option (right to buy)F9 | $84.61 | holding | — | — | — | — | Aug 15, 2030 | Common Stock | 12,649 | 12,649 | D |
| Stock Option (right to buy)F10 | $73.46 | holding | — | — | — | — | May 1, 2031 | Common Stock | 7,327 | 7,327 | D |
| Stock Option (right to buy)F11 | $74.91 | holding | — | — | — | — | Aug 15, 2034 | Common Stock | 17,133 | 17,133 | D |
| Stock Option (right to buy)F12 | $48.61 | holding | — | — | — | — | Jun 2, 2035 | Common Stock | 5,434 | 5,434 | D |
| Stock Option (right to buy)F13 | $53.60 | holding | — | — | — | — | Aug 15, 2035 | Common Stock | 19,151 | 19,151 | D |
| Performance Restricted Stock UnitsF1,F14 | — | holding | — | — | — | — | — | Common Stock | 2,387 | 2,387 | D |
| Restricted Stock UnitsF1,F15 | — | holding | — | — | — | — | — | Common Stock | 735 | 735 | D |
| Stock Option (right to buy)F16 | $57.82 | holding | — | — | — | — | Mar 2, 2036 | Common Stock | 1,911 | 1,911 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- F10Options to purchase 1,832 shares vest on each of 5/1/2025, 5/1/2026 and 5/1/2028; and options to purchase 1,831 shares vest on 5/1/2027.
- F11Options to purchase 4,283 shares vest on each of 8/15/2025, 8/15/2027 and 8/15/2028; and options to purchase 4,284 shares vest on 8/15/2026.
- F12Options to purchase 1,359 shares vest on each of 6/2/2026 and 6/2/2028; and options to purchase 1,358 shares vest on each of 6/2/2027 and 6/2/2029.
- F13Options to purchase 4,788 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2029; and options to purchase 4,787 shares vest on 8/15/2028.
- F14Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F15245 restricted stock units vest on 3/2/2027, 3/2/2028 and 3/2/2029.
- F16Options to purchase 478 shares vest on each of 3/2/2027, 3/2/2028 and 3/2/2030; and options to purchase 477 shares vest on 3/2/2029.
- F2794 restricted stock units vest on 5/1/2027.
- F3600 restricted stock units vest on each of 6/2/2027 and 6/2/2028.
- F41,379 restricted stock units vest on 8/15/2026.
- F51,868 restricted stock units vest on 8/15/2026 and 1,869 restricted stock units vest on 8/15/2027.
- F62,176 restricted stock units vest on each of 8/15/2026 and 8/15/2028; and 2,177 restricted stock units vest on 8/15/2027.
- F7100% vested.
- F8Options to purchase 6,140 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.
- F9Options to purchase 3,162 shares vest on each of 8/15/2024, 8/15/2026 and 8/15/2027; and options to purchase 3,163 shares vest on 8/15/2025.